National Pharmaceutical Pricing Authority notifies retail prices of 41 new drugs: Gireesh Babu, New Delhi Thursday, June 5, 2025, 08:00 Hrs [IST] The National Pharmaceutical Prici ...

The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has directed Zydus ...

Ahmedabad: Zydus Lifesciences Limited has announced that it has entered into a definitive agreement with Agenus Inc. to ...

Agenus, which has been going through a reorganization after the FDA put the brakes on the biotech's regulatory plan for its ...

Zydus also entered into a definitive agreement with Agenus Inc to acquire India and Sri Lanka commercial rights for its investigational Botensilimab (BOT) and Balstilimab (BAL), combination therapy.

Agenus will give Zydus an exclusive licence for the development and commercialisation of BOT and BAL in Sri Lanka and India.

Mumbai: Zydus Lifesciences Ltd is looking to ramp up its vaccines and medtech portfolio over the next few years, the company’s top executive told investors during an earnings call Tuesday evening.

Zydus Lifesciences has received tentative approval from the US Food and Drug Administration to market Rifaximin Tablets in ...

Zydus Wellness Ltd, an Indian consumer goods company that specialises in health and wellness products, on May 19 reported 15% jump in net profit at Rs 172 crore for the quarter ended March 31, 2025.

Zydus Lifesciences’ (Zydus) Q4FY25 revenue gained with healthy traction in US (+20%), domestic branded formulation (+10.7%) and its consumer business (+17.1%). US growth was driven by Mirabegron ...

Lenovo has been selling a line of gaming tablets with 8.8 inch displays and high-end processors for the past few years. Now the company has revealed a 4th-gen model with the fastest processor ...